Your browser doesn't support javascript.
loading
The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression.
Weiss, Julia M; Guérin, Marion V; Regnier, Fabienne; Renault, Gilles; Galy-Fauroux, Isabelle; Vimeux, Lene; Feuillet, Vincent; Peranzoni, Elisa; Thoreau, Maxime; Trautmann, Alain; Bercovici, Nadège.
Afiliação
  • Weiss JM; Inserm, U1016, Institut Cochin, Paris, France.
  • Guérin MV; Cnrs, UMR8104, Paris, France.
  • Regnier F; Université Paris Descartes, Sorbonne Paris Cité, France.
  • Renault G; Inserm, U1016, Institut Cochin, Paris, France.
  • Galy-Fauroux I; Cnrs, UMR8104, Paris, France.
  • Vimeux L; Université Paris Descartes, Sorbonne Paris Cité, France.
  • Feuillet V; Inserm, U1016, Institut Cochin, Paris, France.
  • Peranzoni E; Cnrs, UMR8104, Paris, France.
  • Thoreau M; Université Paris Descartes, Sorbonne Paris Cité, France.
  • Trautmann A; Inserm, U1016, Institut Cochin, Paris, France.
  • Bercovici N; Cnrs, UMR8104, Paris, France.
Oncoimmunology ; 6(10): e1346765, 2017.
Article em En | MEDLINE | ID: mdl-29123960
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article